Sympathetic nervous system and cardiovascular risk in mitral valve prolapse
References
- 1. Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005; 365 (9458): 507–518.
- 2. Hu X, Zhao Q. Autonomic dysregulation as a novel underlying cause of mitral valve prolapse: a hypothesis. Med Sci Monit. 2011;17 (9): 27-31.
- 3. Hu X, Wang H-Z, Liu J, Chen A-Q, Ye X-F, Zhao Q. A novel role of sympathetic activity in regulating mitral valve prolapse. Circ J. 2014; 78 (6): 1486–1493.
- 4. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010; 141 (2): 122–131.
- 5. McEwen BS. Stress, Adaptation, and Disease: Allostasis and Allostatic Load. Ann N Y Acad Sci. 1998; 840: 33–44.
- 6. Tonhajzerova I, Mestanik M. New perspectives in the model of stress response. Physiol Res. 2017; 66 (Suppl 2): 173–185.
- 7. Tonhajzerová I, Mešťaník M. Psychofyziológia: od stresovej odpovede po biofeedback. Martin: VEGA; 2016. 164 pp.
- 8. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens. 2000; 13 (6 Pt 2): 112–122.
- 9. Ma JI, Igata S, Strachan M, Nishimura M, Wong DJ, Raisinghani A, DeMaria A. Predictive Factors for Progression of Mitral Regurgitation in Asymptomatic Patients With Mitral Valve Prolapse. Am J Cardiol. 2019; 123 (8): 1309–1313.
- 10. Sénéchal M, Michaud N, Machaalany J, Bernier M, Dubois M, Magne J, Couture C, Mathieu P, Bertrand OF, Voisine P. Relation of mitral valve morphology and motion to mitral regurgitation severity in patients with mitral valve prolapse. Cardiovasc Ultrasound. 2012; 10: 3.
- 11. Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation. 2014; 129 (21): 2158–2170.
- 12. Shah PM. Current concepts in mitral valve prolapse—Diagnosis and management. J Cardiol. 2010; 56 (2): 125–133.
- 13. Beketova G V, Soldatova O V, Gan R V, Horiacheva IP, Aleksieienko NV, Nekhaienko MI, Zborshchik MV. Daily Profile Of Blood Pressure In Children With Mitral Valve Prolapse. World Med Biol. 2018; 14: 009.
- 14. Grassi G, Bombelli M, Seravalle G, Dell’Oro R, Quarti-Trevano F. Diurnal blood pressure variation and sympathetic activity. Hypertens Res. 2010; 33 (5): 381–385.
- 15. Tsao P, von Zastrow M. Downregulation of G protein-coupled receptors. Curr Opin Neurobiol. 2000; 10 (3): 365–369.
- 16. Pasternac A, Tubau JF, Puddu PE, Król RB, De Champlain J. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med. 1982; 73 (6): 783–790.
- 17. Han H, Ha FJ, Teh AW, Calafiore P, Jones EF, Johns J, Koshy AN, O'Donnell D, Hare DL, Farouque O, Lim HS. Mitral Valve Prolapse and Sudden Cardiac Death: A Systematic Review. J Am Heart Assoc. 2018; 7 (23): e010584.
- 18. Öztürk C, Schueler R, Weber M, Welz A, Werner N, Nickenig G, Hammerstingl C. Sympathetic Activity in Patients With Secondary Symptomatic Mitral Regurgitation or End-Stage Systolic Heart Failure. JACC Cardiovasc Interv. 2016; 9 (19): 2050–2057.
- 19. Antoine C, Mantovani F, Benfari G, Mankad S V, Maalouf JF, Michelena HI, Enriquez-Sarano M. Pathophysiology of Degenerative Mitral Regurgitation. Circ Cardiovasc Imaging. 2018; 11 (1): e005971.
- 20. Monin J-L, Dehant P, Roiron C, Monchi M, Tabet J-Y, Clerc P, Fernandez G, Houel R, Garot J, Chauel C, Gueret P. Functional Assessment of Mitral Regurgitation by Transthoracic Echocardiography Using Standardized Imaging Planes: Diagnostic Accuracy and Outcome Implications. J Am Coll Cardiol. 2005; 46 (2): 302–309.
- 21. Delling FN, Kang LL, Yeon SB, Kissinger K V, Goddu B, Manning WJ, Han Y. CMR Predictors of Mitral Regurgitation in Mitral Valve Prolapse. JACC Cardiovasc Imaging. 2010; 3 (10): 1037–1045.
- 22. Shah SN, Oliver TI. Mitral Valve Prolapse. StatPearls. StatPearls Publishing; 2018.
- 23. Mohty D, Orszulak TA, Schaff H V, Avierinos J-F, Tajik JA, Enriquez-Sarano M. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse. Circulation. 2001; 104 (12 Suppl 1): 1–7.
- 24. Markham R, Kyranis S, Aroney N, Lau K, Poon K, Scalia G, Walters D. Transcatheter mitral valve intervention: an emerging treatment for mitral regurgitation. Intern Med J. 2018; 48 (4): 382–390.
- 25. Henry DP, Luft FC, Weinberger MH, Fineberg NS, Grim CE. Norepinephrine in urine and plasma following provocative maneuvers in normal and hypertensive subjects. Hypertension. 1980; 2: 20–28.
- 26. Grassi G, Bombelli M, Brambilla G, Trevano FQ, Dell'Oro R, Mancia G. Total Cardiovascular Risk, Blood Pressure Variability and Adrenergic Overdrive in Hypertension: Evidence, Mechanisms and Clinical Implications. Curr Hypertens Rep. 2012; 14 (4): 333–338.
- 27. Stauss HM. Idetification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol. 2007; 34 (4): 362–368.
- 28. Di Rienzo M, Parati G, Radaelli A, Castiglioni P. Baroreflex contribution to blood pressure and heart rate oscillations: time scales, time-variant characteristics and nonlinearities. Philos Trans A Math Phys Eng Sci. 2009; 367 (1892): 1301–1318.
- 29. Coupé M, Fortrat JO, Larina I, Gaugein-Koch G, Gharib C, Custaud MA. Cardiovascular deconditioning: From autonomic nervous system to microvascular dysfunctions. Respir Physiol Neurobiol. 2009; 169 (Suppl 1): 10–12.
- 30. Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Circ Physiol. 2002; 282 (1): 6–20.
- 31. Visnovcova Z, Mestanik M, Gala M, Mestanikova A, Tonhajzerova I. The complexity of electrodermal activity is altered in mental cognitive stressors. Comput Biol Med. 2016; 79: 123–129.
- 32. Stanton N, Hedge A, Brookhuis K, Salas E, Hendrick HW, editors, editors. Handbook of Human Factors and Ergonomics Methods. CRC Press; 2004. 764 pp.
- 33. Boucsein W. Electrodermal activity. New York: Springer Science+Business Media, LLC; 2012. 618 pp.
- 34. Yucha C, Montgomery D, Association for Applied Psychophysiology and Biofeedback. Evidence-based practice in biofeedback and neurofeedback. AAPB; 2008. 81 pp.
- 35. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Bacquer D, Ducimetriére P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24 (11): 987–1003.
Language: English
Page range: 51 - 57
Submitted on: Apr 18, 2019
Accepted on: May 30, 2019
Published on: Jul 27, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 times per year
Keywords:
Related subjects:
© 2019 L Bona Olexova, M Mestanik, A Jurko, N Sekaninova, M Slavikova, I Tonhajzerova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.